Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use

Saccharomyces cerevisiae has recently been used as an ingredient in probiotic supplements. Invasive Saccharomyces infection have been documented, and multiple predisposing risk factors have been identified including critical illness, ICU admission, antibiotics use, central venous catheters, probioti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Med Mycol Case Rep
Autores principales: Fadhel, Mustafa, Patel, Swapnil, Liu, Edward, Levitt, Michael, Asif, Arif
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251791/
https://ncbi.nlm.nih.gov/pubmed/30505677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mmcr.2018.11.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares